Renal Cancer - Results from #7700

A comparison of pathologic outcomes of matched robotic and open partial nephrectomies - Abstract June 6, 2013

Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients - Abstract June 6, 2013

Clear cell renal cell carcinoma: Discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT - Abstract June 5, 2013

Prognostic models and factors for patients with renal-cell carcinoma: A survey on their use among urologists - Abstract June 5, 2013

13-Year-old tuberous sclerosis patient with renal cell carcinoma associated with multiple renal angiomyolipomas developing multifocal micronodular pneumocyte hyperplasia - Abstract June 5, 2013

Therapeutic challenges in advanced renal cell carcinoma - Abstract June 5, 2013

Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk - Abstract June 5, 2013

Thulium laser supported nephron sparing surgery for renal cell carcinoma - Abstract June 5, 2013

Oral and intravenously administered mTOR inhibitors for metastatic renal cell carcinoma: Pharmacokinetic considerations and clinical implications - Abstract June 5, 2013

Expression of drug targets in primary and matched metastatic renal cell carcinoma tumors - Abstract June 5, 2013

Fenoldopam and renal function after partial nephrectomy in a solitary kidney: A randomized, blinded trial - Abstract June 4, 2013

The imaging and pathological features of a mucinous tubular and spindle cell carcinoma of the kidney: A case report - Abstract June 4, 2013

Low-grade clear cell renal cell carcinoma mimicking hemangioma of the kidney: A series of 4 cases - Abstract June 4, 2013

Advanced native kidney renal cell carcinoma in renal transplant recipients: Role of sirolimus as dual anti-cancer and anti-rejection agent - Abstract June 4, 2013

Metastasis of renal cell carcinoma to the bladder - Abstract May 31, 2013

Phase II trial of sequential subcutaneous interleukin-2 plus interferon alpha followed by sorafenib in renal cell carcinoma (RCC) - Abstract May 31, 2013

Axitinib for the treatment of metastatic renal cell carcinoma: Recommendations for therapy management to optimize outcomes - Abstract May 31, 2013

Metastatic renal cell carcinoma to the thyroid gland 24 years after the primary tumour - Abstract May 31, 2013

A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma. A trial of the PMH phase 2 consortium - Abstract May 31, 2013

Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinoma - Abstract May 31, 2013

Page 386 of 457